FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078089300> ?p ?o ?g. }

• W2078089300 endingPage "117" @default.
• W2078089300 startingPage "103" @default.
• W2078089300 abstract "To examine whether intensive glycemic control could decrease the frequency or severity of diabetic microvascular complications, we performed a prospective study of Japanese patients with non-insulin-dependent diabetes mellitus (NIDDM) treated with multiple insulin injection treatment. A total of 110 patients with NIDDM was randomly assigned to multiple insulin injection treatment group (MIT group) or to conventional insulin injection treatment group (CIT group). Fifty-five NIDDM patients who showed no retinopathy and urinary albumin excretions < 30 mg/24 h at the baseline were evaluated in the primary-prevention cohort, and the other 55 NIDDM patients who showed simple retinopathy and urinary albumin excretions < 300 mg/24 h were evaluated in the secondary-intervention cohort. The appearance and the progression of retinopathy, nephropathy and neuropathy were evaluated every 6 months over a 6-year period. The worsening of complications in this study was defined as an increase of 2 or more steps in the 19 stages of the modified ETDRS interim scale for retinopathy and an increase of one or more steps in 3 stages (normoalbuminuria, microalbuminuria and albuminuria) for nephropathy. The cumulative percentages of the development and the progression in retinopathy after 6 years were 7.7% for the MIT group and 32.0% for the CIT group in the primary-prevention cohort (P = 0.039), and 19.2% for MIT group and 44.0% for CIT group in the secondary-intervention cohort (P = 0.049). The cumulative percentages of the development and the progression in nephropathy after 6 years were 7.7% for the MIT group and 28.0% for the CIT group in the primary-prevention cohort (P = 0.032), and 11.5% and 32.0%, respectively, for the MIT and CIT groups in the secondary-intervention cohort (P = 0.044). In neurological tests after 6 years, MIT group showed significant improvement in the nerve conduction velocities, while the CIT group showed significant deterioration in the median nerve conduction velocities and vibration threshold. Although both postural hypotension and the coefficient of variation of R-R interval tended to improve in the MIT group, they deteriorated in the CIT group. In conclusion, intensive glycemic control by multiple insulin injection therapy can delay the onset and the progression of diabetic retinopathy, nephropathy and neuropathy in Japanese patients with NIDDM. From this study, the glycemic threshold to prevent the onset and the progression of diabetic microangiopathy is indicated as follows; HbA1c < 6.5%, FBG < 110 mg/dl, and 2-h post-prandial blood glucose concentration < 180 mg/dl." @default.
• W2078089300 created "2016-06-24" @default.
• W2078089300 creator A5006754711 @default.
• W2078089300 creator A5006810461 @default.
• W2078089300 creator A5011032439 @default.
• W2078089300 creator A5011056948 @default.
• W2078089300 creator A5012686566 @default.
• W2078089300 creator A5032215965 @default.
• W2078089300 creator A5048243236 @default.
• W2078089300 creator A5067248419 @default.
• W2078089300 creator A5083154252 @default.
• W2078089300 date "1995-05-01" @default.
• W2078089300 modified "2023-10-11" @default.
• W2078089300 title "Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study" @default.
• W2078089300 cites W1591417018 @default.
• W2078089300 cites W1971918320 @default.
• W2078089300 cites W1972572145 @default.
• W2078089300 cites W1974785275 @default.
• W2078089300 cites W1984137307 @default.
• W2078089300 cites W1992573754 @default.
• W2078089300 cites W1994752781 @default.
• W2078089300 cites W2006672342 @default.
• W2078089300 cites W2027692584 @default.
• W2078089300 cites W2044293101 @default.
• W2078089300 cites W2046572753 @default.
• W2078089300 cites W2057986301 @default.
• W2078089300 cites W2059571085 @default.
• W2078089300 cites W2082335785 @default.
• W2078089300 cites W2088865109 @default.
• W2078089300 cites W2090777632 @default.
• W2078089300 cites W2094557444 @default.
• W2078089300 cites W2100173336 @default.
• W2078089300 cites W2115579244 @default.
• W2078089300 cites W2120304420 @default.
• W2078089300 cites W2322256252 @default.
• W2078089300 cites W2769264260 @default.
• W2078089300 cites W4205266458 @default.
• W2078089300 cites W4230533844 @default.
• W2078089300 cites W4232564846 @default.
• W2078089300 cites W4237162630 @default.
• W2078089300 cites W4240531687 @default.
• W2078089300 cites W4244248663 @default.
• W2078089300 cites W4252759459 @default.
• W2078089300 doi "https://doi.org/10.1016/0168-8227(95)01064-k" @default.
• W2078089300 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7587918" @default.
• W2078089300 hasPublicationYear "1995" @default.
• W2078089300 type Work @default.
• W2078089300 sameAs 2078089300 @default.
• W2078089300 citedByCount "2833" @default.
• W2078089300 countsByYear W20780893002012 @default.
• W2078089300 countsByYear W20780893002013 @default.
• W2078089300 countsByYear W20780893002014 @default.
• W2078089300 countsByYear W20780893002015 @default.
• W2078089300 countsByYear W20780893002016 @default.
• W2078089300 countsByYear W20780893002017 @default.
• W2078089300 countsByYear W20780893002018 @default.
• W2078089300 countsByYear W20780893002019 @default.
• W2078089300 countsByYear W20780893002020 @default.
• W2078089300 countsByYear W20780893002021 @default.
• W2078089300 countsByYear W20780893002022 @default.
• W2078089300 countsByYear W20780893002023 @default.
• W2078089300 crossrefType "journal-article" @default.
• W2078089300 hasAuthorship W2078089300A5006754711 @default.
• W2078089300 hasAuthorship W2078089300A5006810461 @default.
• W2078089300 hasAuthorship W2078089300A5011032439 @default.
• W2078089300 hasAuthorship W2078089300A5011056948 @default.
• W2078089300 hasAuthorship W2078089300A5012686566 @default.
• W2078089300 hasAuthorship W2078089300A5032215965 @default.
• W2078089300 hasAuthorship W2078089300A5048243236 @default.
• W2078089300 hasAuthorship W2078089300A5067248419 @default.
• W2078089300 hasAuthorship W2078089300A5083154252 @default.
• W2078089300 hasConcept C126322002 @default.
• W2078089300 hasConcept C134018914 @default.
• W2078089300 hasConcept C141071460 @default.
• W2078089300 hasConcept C188816634 @default.
• W2078089300 hasConcept C2776174234 @default.
• W2078089300 hasConcept C2778313320 @default.
• W2078089300 hasConcept C2779306644 @default.
• W2078089300 hasConcept C2779829184 @default.
• W2078089300 hasConcept C2779922275 @default.
• W2078089300 hasConcept C2780473172 @default.
• W2078089300 hasConcept C2781184683 @default.
• W2078089300 hasConcept C2781203188 @default.
• W2078089300 hasConcept C555293320 @default.
• W2078089300 hasConcept C71924100 @default.
• W2078089300 hasConcept C72563966 @default.
• W2078089300 hasConcept C90924648 @default.
• W2078089300 hasConceptScore W2078089300C126322002 @default.
• W2078089300 hasConceptScore W2078089300C134018914 @default.
• W2078089300 hasConceptScore W2078089300C141071460 @default.
• W2078089300 hasConceptScore W2078089300C188816634 @default.
• W2078089300 hasConceptScore W2078089300C2776174234 @default.
• W2078089300 hasConceptScore W2078089300C2778313320 @default.
• W2078089300 hasConceptScore W2078089300C2779306644 @default.
• W2078089300 hasConceptScore W2078089300C2779829184 @default.
• W2078089300 hasConceptScore W2078089300C2779922275 @default.
• W2078089300 hasConceptScore W2078089300C2780473172 @default.
• W2078089300 hasConceptScore W2078089300C2781184683 @default.

• next